Earnings Feed
Start Free
Home/Insiders/Kaseta Michael
KM
SEC Insider//CIK 0001724346

Kaseta Michael

CIK 00017243464 companiesMORRISVILLE, NC
SEC Profile

Transactions

50

Companies

4

Filings

8

CIK

0001724346

Recent Transactions

50 trades
  • Award
    Liquidia Corp$LQDA

    Performance Stock Units

    2026-01-16+88,980→ 88,980 total
  • Award
    Liquidia Corp$LQDA

    Common Stock

    2026-01-16+59,320→ 410,239 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-01-12$37.43/sh−36,932→ 350,919 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Performance Stock Units

    2026-01-09−5,828→ 46,625 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Common Stock

    2026-01-09+5,828→ 359,651 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Common Stock

    2026-01-09+28,200→ 387,851 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Performance Stock Units

    2026-01-09−28,200→ 84,597 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2025-12-01$32.19/sh−1,166→ 353,823 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Restricted Stock Units

    2025-11-28−2,343→ 2,344 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Common Stock

    2025-11-28+2,343→ 354,989 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2025-10-13$23.41/sh−11,630→ 352,646 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Performance Stock Unit

    2025-10-10−5,828→ 52,453 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Common Stock

    2025-10-10+5,828→ 364,276 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2025-09-02$29.05/sh−1,148→ 358,448 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Restricted Stock Unit

    2025-08-31−2,344→ 4,687 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Common Stock

    2025-08-29+2,344→ 359,596 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2025-08-15$26.18/sh−20,000→ 356,412 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2025-08-05$20.00/sh−30,000→ 376,412 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2025-07-14$14.28/sh−11,580→ 406,412 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Common Stock

    2025-07-11+5,828→ 417,992 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Performance Stock Units

    2025-07-11−5,828→ 58,281 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2025-06-04$16.97/sh−14,777→ 412,164 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Common Stock

    2025-06-03+29,141→ 426,941 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Performance Stock Units

    2025-06-03−29,141→ 64,109 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2025-06-02$16.74/sh−859→ 397,800 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Restricted Stock Unit

    2025-05-30−2,344→ 7,031 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Common Stock

    2025-05-30+2,344→ 398,659 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2025-04-14$13.57/sh−8,283→ 396,315 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2025-03-03$15.45/sh−874→ 404,598 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Common Stock

    2025-02-28+2,344→ 405,472 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Restricted Stock Unit

    2025-02-28−2,344→ 9,375 total
  • Award
    HERON THERAPEUTICS, INC. /DE/$HRTX

    Stock Option (Right to Buy)

    2025-01-31+35,900→ 35,900 total
  • Award
    HERON THERAPEUTICS, INC. /DE/$HRTX

    Common Stock

    2025-01-31+17,950→ 55,829 total
  • Award
    HERON THERAPEUTICS, INC. /DE/$HRTX

    Stock Option (Right to Buy)

    2025-01-30$1.73/sh+35,900→ 35,900 total
  • Award
    HERON THERAPEUTICS, INC. /DE/$HRTX

    Common Stock

    2025-01-30+17,950→ 55,829 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2025-01-14$11.78/sh−23,370→ 401,755 total
  • Award
    Liquidia Corp$LQDA

    Common Stock

    2025-01-11+112,797→ 425,125 total
  • Award
    Liquidia Corp$LQDA

    Performance Stock Units

    2025-01-11+112,797→ 112,797 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2024-12-02$11.51/sh−1,091→ 312,328 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Restricted Stock Unit

    2024-11-30−2,343→ 11,719 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Common Stock

    2024-11-30+2,343→ 313,419 total
  • Award
    HERON THERAPEUTICS, INC. /DE/$HRTX

    Stock Option (Right to Buy)

    2024-11-04$1.78/sh+227,272→ 227,272 total
  • Award
    HERON THERAPEUTICS, INC. /DE/$HRTX

    Common Stock

    2024-11-04+37,879→ 37,879 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2024-10-14$11.11/sh−3,892→ 311,076 total
  • Disposition to Issuer
    ALIMERA SCIENCES INC

    Stock Option (Right to Buy)

    2024-09-16−50,000→ 0 total
  • Disposition to Issuer
    ALIMERA SCIENCES INC

    Stock Option (Right to Buy)

    2024-09-16−1,825→ 0 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2024-09-03$9.50/sh−1,079→ 314,968 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Restricted Stock Unit

    2024-08-30−2,344→ 14,062 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Common Stock

    2024-08-30+2,344→ 316,047 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2024-07-12$12.53/sh−3,906→ 312,389 total

Companies

4

Recent Filings

8

Address

419 DAVIS DRIVE, SUITE 100

MORRISVILLE, NC, 27560

View on SEC.gov